Treatment-resistant depression (TRD) occurs when two or more antidepressants of an adequate dose are taken but fail to deliver sufficient relief to the individual. To help treat TRD, SPRAVATO™ is a prescription medicine that can be used along with an anti-depressant to provide relief.
In contrast to traditional oral antidepressants, SPRAVATO™ is a nasal spray that works by targeting the N-methyl-D-aspartate (NMDA). The effectiveness of SPRAVATO™ is backed by a short-term clinical study of adults with TRD. Those who were administered SPRAVATO™ along with an oral depressant, compared to those who received a placebo with an oral depressant, experienced at least 50% improvement.
If you struggle with TRD and are looking for relief, give us a call to see if SPRAVATO™ is right for you.
In-Person, Telehealth, and House Calls Available